Welcome to our dedicated page for Ingevity SEC filings (Ticker: NGVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ingevity Corporation (NYSE: NGVT) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered context to help interpret them. Ingevity is a specialty materials and chemical manufacturer organized into three segments—Performance Materials, Advanced Polymer Technologies and Performance Chemicals—and its filings document how these businesses are managed, restructured and financed over time.
Investors can use Ingevity’s Form 10-K annual reports and Form 10-Q quarterly reports to review segment information, including sales and EBITDA for Performance Materials (activated carbon), Advanced Polymer Technologies (caprolactone polymers) and Performance Chemicals (specialty chemicals and pavement or road technologies). These reports also describe the applications for Ingevity’s products, such as adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings, lubricants, oil drilling and automotive components.
Ingevity’s Form 8-K current reports are particularly important for tracking material events that affect NGVT stock. Recent 8-K filings detail the asset purchase agreement and subsequent amendment with Mainstream Pine Products, LLC for the sale of the North Charleston crude tall oil refinery and the majority of the Industrial Specialties product line, the classification of those operations as discontinued, and the completion of the transaction. Other 8-Ks describe leadership transitions in finance and business segments, the completion of a portfolio review and the decision to explore strategic alternatives for the Advanced Polymer Technologies segment and the Performance Chemicals Road Markings business, as well as preliminary earnings announcements.
On this page, AI-generated summaries highlight the key points of each filing, helping users quickly understand what a lengthy 8-K, 10-Q or 10-K means for Ingevity’s portfolio, margins, cash flow and capital allocation. Filings related to stock repurchases, strategic divestitures and executive changes are surfaced so that investors can monitor how the company is reshaping its specialty chemicals and materials portfolio. Users can also review exhibits referenced in 8-Ks, such as asset purchase agreements and recast financial information, to gain deeper insight into the structure and impact of major transactions.
Ingevity Corporation is updating how it reports its results to reflect a planned divestiture of major businesses. The company has an Asset Purchase Agreement with Mainstream Pine Products, LLC for the sale of substantially all assets and certain liabilities of its industrial specialties product line (excluding specified products and businesses) and its North Charleston, South Carolina crude tall oil refinery, with closing expected by early 2026.
Ingevity determined that these operations meet the criteria to be classified as held for sale and that the divestiture represents a strategic shift that will have a major effect on its operations and results. As a result, the industrial specialties product line and the refinery are now presented as discontinued operations for all periods shown. Ingevity is furnishing unaudited recast condensed consolidated statements of operations, segment operating results, and certain non-GAAP financial measures for full-year 2024 and 2023 and multiple 2024–2025 quarters, which apply these changes retrospectively and are described as preliminary.
Ingevity Corp (NGVT) insider filing reports no beneficial ownership. A company officer, identified as the Senior Vice President and President of Performance Materials, filed an initial ownership report on Form 3 as of 11/10/2025. The filing states that no securities are beneficially owned by the reporting person at this time. The form is submitted as an individual filing and includes a power of attorney authorizing an attorney-in-fact to sign on the reporting person’s behalf.
Ingevity Corporation (NGVT) reported steady Q3 2025 results. Net sales were $333.1 million versus $333.8 million a year ago, and gross profit rose to $133.9 million from $131.6 million. Income from continuing operations before taxes was $62.2 million (vs. $54.0 million), with net income of $43.5 million. Diluted EPS was $1.18 versus $(2.94), reflecting a large discontinued-operations loss in the prior year. The effective tax rate was 34.4%.
Year‑to‑date, net sales were $912.5 million (vs. $936.8 million) and net loss was $(82.5) million, driven by a non‑cash $183.8 million goodwill impairment in Advanced Polymer Technologies. Operating cash flow improved to $234.1 million (vs. $64.1 million). Total debt including finance leases declined to $1.2639 billion from $1.4052 billion, and interest expense fell to $56.4 million (vs. $69.3 million). Revolver covenants remained comfortable, with net leverage at 2.7x and interest coverage at 5.5x.
The company signed an Asset Purchase Agreement on September 3, 2025 to divest its industrial specialties product line and North Charleston CTO refinery, which are presented as discontinued operations; closing is expected by early 2026. During Q3, NGVT repurchased $25.2 million of stock, or 445,724 shares at a weighted average of $56.09.
Ingevity Corporation furnished preliminary financial results for the three and nine months ended September 30, 2025. The details are provided in a press release attached as Exhibit 99.1, dated November 5, 2025. The information under Item 2.02, including Exhibit 99.1, is being furnished and is not deemed filed under the Securities Exchange Act. Additional materials may be available on Ingevity’s investor relations website.
Victory Capital Management, Inc. filed an amended Schedule 13G (Amendment No. 1) reporting beneficial ownership of 782,930 shares of Ingevity Corp (NGVT) common stock, representing 2.15% of the class as of 09/30/2025. The filer is classified as an investment adviser (IA).
Victory reports 766,969 shares with sole voting power and 782,930 shares with sole dispositive power, with no shared voting or dispositive power. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Ingevity Corporation appointed Ruth Castillo as Senior Vice President and President, Performance Materials, effective November 10, 2025. She will report directly to the President and Chief Executive Officer.
Castillo brings over 25 years of experience across chemicals, specialty materials and life sciences, most recently serving as Vice President of Global Chemicals at Avantor. Prior roles at Avantor included business transformation, supply chain and engineering, and global product management, following 17 years in leadership positions at Celanese. She holds an MBA from the University of Texas at Dallas and a B.S. in Chemical Engineering from Universidad Iberoamericana. The company disclosed no family relationships, selection arrangements, or related-party transactions.
Ingevity Corp (NGVT) director Luis Fernandez-Moreno reported a sale and adjustments to his holdings tied to restricted stock units. On 10/02/2025 he disposed of 6,004 shares of common stock at $56.31, leaving him with 35,978 shares beneficially owned after the transaction. The filing explains the sale and ownership change arose from RSU activity: shares were withheld to satisfy tax withholding for RSUs that vested on 10/02/2025, and 11,123 RSUs were forfeited because his interim CEO role ended before the one-year anniversary of that RSU grant.
The Form 4 was filed as an individual report and bears a signature submitted by an attorney-in-fact on behalf of Mr. Fernandez-Moreno on 10/06/2025. The disclosure presents a routine insider tax-withholding sale and a forfeiture tied to termination of an interim executive role; both items materially change the director's reported holdings but do not allege any misconduct.
Francis David Segal, a director of Ingevity Corp (NGVT), reported acquiring 414 vested deferred stock units on 10/01/2025 at a recorded price of $54.44 per share equivalent. These DSUs were elected in lieu of quarterly director fees and will convert into an equal number of common shares when Mr. Segal leaves board service under the company's Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. After this transaction, his reported beneficial ownership is 5,655 shares, held directly.
J. Kevin Willis, a director of Ingevity Corp (NGVT), reported a transaction dated 10/01/2025 in which he acquired 506 shares of Common Stock at a price of $54.44 per share. The Form 4 shows the shares represent vested deferred stock units that were elected in lieu of quarterly director fees and will convert into common shares upon his termination of board service under the company plans. After the reported transaction the filing shows the reporting person beneficially owned 8,300 shares directly. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Ingevity Corporation has agreed to sell substantially all assets of its industrial specialties product line (excluding lignin dispersant, alternative fatty acid based products, road technologies and certain other businesses) and its North Charleston, South Carolina crude tall oil refinery to Mainstream Pine Products, LLC under an Asset Purchase Agreement.
The Transaction provides for a purchase price of $110 million in cash, subject to customary working capital adjustments, plus up to an additional $19 million in contingent consideration based on the Businesses’ highest EBITDA over any 12‑month period within 36 months after closing. Closing is expected by early Q1 2026, subject to regulatory and contractual conditions, including absence of a Material Adverse Effect and completion of title and survey work.
The Agreement includes mutual termination rights, a $5 million termination fee for certain material breaches, a $7.5 million fee if Ingevity pursues an Alternative Transaction in violation of a “no shop” covenant, and a $520,000 diligence fee payable by Ingevity in most other termination scenarios. At closing, the parties plan to enter long‑term ground lease and reciprocal plant operating agreements (each with an initial 20‑year term and renewal options), transition services, intellectual property, restrictive covenant and environmental indemnity agreements that will govern ongoing collaboration around the refinery and nearby plant operations.